Skip to main content
. 2019 Jul 5;23(9):6295–6307. doi: 10.1111/jcmm.14515

Figure 3.

Figure 3

miR‐516a‐3p inhibits breast cancer cell growth in vitro. A, The proliferation ability of MCF‐7 and MDA‐MB‐231 cells after treatment with miR‐516a‐3p mimic was examined with a CCK‐8 kit. B, The proliferation ability of MCF‐7 and MDA‐MB‐231 cells after treatment with miR‐516a‐3p inhibitor was examined with a CCK‐8 assay. C, The cell apoptosis was analyzed in MCF‐7 and MDA‐MB‐231 cells transfected with miR‐516a‐3p NC or miR‐516a‐3p mimic. D, The cell apoptosis was analyzed in MCF‐7 and MDA‐MB‐231 cells transfected with miR‐516a‐3p NC or miR‐516a‐3p inhibitor. Data are shown as mean ± SD (*, P < 0.05; **, P < 0.01; ***, P < 0.001)